Mufg Americas Holdings Corp Alnylam Pharmaceuticals, Inc. Transaction History

Mufg Americas Holdings Corp

$0
Q3 2023

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Dec 01, 2022	BUY	$138.54 - $232.0 $1,801 - $3,016	13 Added 0.7%	1,880 $376,000
Q3 2022 Oct 31, 2022	BUY	$138.54 - $232.0 $1,801 - $3,016	13 Added 0.7%	1,880 $376,000
Q2 2022 Dec 01, 2022	BUY	$120.42 - $169.29 $6,141 - $8,633	51 Added 2.81%	1,867 $272,000
Q2 2022 Aug 02, 2022	BUY	$120.42 - $169.29 $6,141 - $8,633	51 Added 2.81%	1,867 $272,000
Q1 2022 Dec 01, 2022	BUY	$127.18 - $173.91 $7,757 - $10,608	61 Added 3.48%	1,816 $297,000
Q1 2022 May 06, 2022	BUY	$127.18 - $173.91 $7,757 - $10,608	61 Added 3.48%	1,816 $297,000
Q4 2021 Dec 01, 2022	BUY	$159.56 - $209.29 $14,200 - $18,626	89 Added 5.34%	1,755 $298,000
Q4 2021 Feb 09, 2022	BUY	$159.56 - $209.29 $14,200 - $18,626	89 Added 5.34%	1,755 $298,000
Q3 2021 Dec 01, 2022	BUY	$169.75 - $207.73 $1,358 - $1,661	8 Added 0.48%	1,666 $315,000
Q3 2021 Nov 05, 2021	BUY	$169.75 - $207.73 $1,358 - $1,661	8 Added 0.48%	1,666 $315,000
Q2 2021 Dec 01, 2022	BUY	$128.63 - $176.89 $53,767 - $73,940	418 Added 33.71%	1,658 $281,000
Q2 2021 Aug 06, 2021	BUY	$128.63 - $176.89 $53,767 - $73,940	418 Added 33.71%	1,658 $281,000
Q1 2021 Dec 01, 2022	BUY	$126.83 - $175.69 $33,736 - $46,733	266 Added 27.31%	1,240 $175,000
Q1 2021 Apr 30, 2021	BUY	$126.83 - $175.69 $33,736 - $46,733	266 Added 27.31%	1,240 $175,000
Q4 2020 Dec 01, 2022	BUY	$122.97 - $147.0 $30,742 - $36,750	250 Added 34.53%	974 $127,000
Q4 2020 Feb 03, 2021	BUY	$122.97 - $147.0 $30,742 - $36,750	250 Added 34.53%	974 $127,000
Q3 2020 Dec 01, 2022	BUY	$121.19 - $165.49 $20,117 - $27,471	166 Added 29.75%	724 $106,000
Q3 2020 Nov 03, 2020	BUY	$121.19 - $165.49 $20,117 - $27,471	166 Added 29.75%	724 $106,000
Q2 2020 Dec 01, 2022	SELL	$104.21 - $156.44 $137,765 - $206,813	-1,322 Reduced 70.32%	558 $82,000
Q2 2020 Aug 06, 2020	BUY	$104.21 - $156.44 $58,149 - $87,293	558 New	558 $82,000

Others Institutions Holding ALNY

# of Institutions

644

Shares Held

109M

Call Options Held

1.28M

Put Options Held

1.21M

Capital World Investors Los Angeles, CA

16.5M
Shares

$4.2 Billion
0.73% of portfolio
Vanguard Group Inc Valley Forge, PA

12.6M
Shares

$3.21 Billion
0.06% of portfolio
Black Rock Inc. New York, NY

9.55M
Shares

$2.43 Billion
0.05% of portfolio
Capital Research Global Investors Los Angeles, CA

5.24M
Shares

$1.33 Billion
0.31% of portfolio
Wellington Management Group LLP Boston, MA

4.95M
Shares

$1.26 Billion
0.24% of portfolio

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $31.3B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mufg Americas Holdings Corp, based on Form 13F filings with the SEC.

News

Stay updated on Mufg Americas Holdings Corp with notifications on news.

Account